{
  "ptid_time": "052_S_1352_2018-09-13",
  "img_path": "/data/qiuhui/data/adni/images/052_S_1352/2018-09-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 55,627 mm³, 13.8% above the reference mean. With a Z-score of 1.25 (89.4th percentile), this represents mild enlargement; hippocampal volume measures 6,477 mm³, 1.7% above the reference mean. With a Z-score of 0.18 (57.3th percentile), this represents normal volume ; whole brain volume measures 980,297 mm³, 2.1% below the reference mean. With a Z-score of -0.36 (35.8th percentile), this represents normal volume ; entorhinal cortex volume measures 4,299 mm³, 8.7% above the reference mean. With a Z-score of 0.45 (67.3th percentile), this represents normal volume ; fusiform gyrus volume measures 20,176 mm³, 19.7% above the reference mean. With a Z-score of 2.27 (98.9th percentile), this represents significant enlargement; middle temporal gyrus volume measures 16,023 mm³, 15.0% below the reference mean. With a Z-score of -2.31 (1.1th percentile), this represents significant atrophy. ",
  "text_data": "Age is 97.4 years. Gender is Male. Education: 16 years. MMSE: 27.0. MoCA: 24.0. Logical Memory: 5.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.04 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the middle temporal gyrus (Z-score -2.31, 1.1th percentile), which is strongly associated with Alzheimer's pathology, while hippocampal and whole-brain volumes remain normal. The MMSE (27) and MoCA (24) scores suggest mild cognitive impairment (MCI), particularly given the MoCA score is below the typical cutoff (26). The absence of APOE4 and normal AV45 (amyloid PET) may suggest non-amyloid pathology, but the temporal atrophy is concerning for neurodegenerative disease.  \n\n**Diagnosis:** **MCI** (likely non-amyloid etiology, possibly primary age-related tauopathy or PART given the temporal atrophy).  \n\n**Confidence:** **Medium** (atypical profile with normal amyloid but significant temporal atrophy; age 97 complicates interpretation due to advanced neurodegeneration).",
  "timestamp": "2025-07-26T07:48:31.865471"
}